SAGE - Sage Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts17171718
Avg. Estimate-3.35-3.38-13.34-11.94
Low Estimate-3.63-3.76-14.54-16.21
High Estimate-3-2.82-11.34-6.65
Year Ago EPS-0.36-2.63-8.08-13.34
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts17171819
Avg. Estimate270k3.45M19.36M116M
Low EstimateN/AN/A6.34M25.5M
High Estimate2M15M83.67M264.4M
Year Ago Sales90MN/A90.27M19.36M
Sales Growth (year/est)-99.70%N/A-78.60%499.20%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-1.89-2.42-2.92-3.25
EPS Actual-0.36-2.63-3.38-3.37
Difference1.53-0.21-0.46-0.12
Surprise %81.00%-8.70%-15.80%-3.70%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-3.35-3.38-13.34-11.94
7 Days Ago-3.35-3.38-13.34-11.94
30 Days Ago-3.28-3.3-13.03-11.23
60 Days Ago-3.34-3.35-13.02-11.11
90 Days Ago-3.16-3.24-10.85-9.39
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days6658
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesSAGEIndustrySectorS&P 500
Current Qtr.-830.60%N/AN/A0.02
Next Qtr.-28.50%N/AN/A0.04
Current Year-65.10%N/AN/A0.05
Next Year10.50%N/AN/A0.11
Next 5 Years (per annum)13.10%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A